Evaluation of Hybrid PET/MRI for Gross Tumor Volume (GTV) Delineation in Colorectal Cancer Liver Metastases Radiotherapy

References

• Koshariya M, Jagad RB, Kawamoto J, et al. An update and our experience with metastatic liver disease. Hepatogastroenterology. 2007;54(80):2232–2239.18265640
   PubMedGoogle Scholar
• Paley MR, Ros PR. Hepatic metastases. Radiol Clin North Am. 1998;36(2):349–363. doi:10.1016/S0033-8389(05)70027-09520987
   PubMed Web of Science ®Google Scholar
• Robin TP, Raben D, Schefter TE. A contemporary update on the role of stereotactic body radiation therapy (SBRT) for liver metastases in the evolving landscape of oligometastatic disease management. Semin Radiat Oncol. 2018;28(4):288–294. doi:10.1016/j.semradonc.2018.06.00930309639
   PubMed Web of Science ®Google Scholar
• National comprehensive cancer network (NCCN) clinical practice guidelines in oncology. Colon Cancer. Version 2.2021. 2021.
   Google Scholar
• National comprehensive cancer network (NCCN) clinical practice guidelines in oncology. Rectal Cancer. Version 1.2021. 2021.
   Google Scholar
• Petrelli F, Comito T, Barni S, Pancera G, Scorsetti M, Ghidini A. Stereotactic body radiotherapy for colorectal cancer liver metastases: a systematic review. Radiother Oncol. 2018;129(3):427–434. doi:10.1016/j.radonc.2018.06.03529997034
   PubMed Web of Science ®Google Scholar
• Joo JH, Park JH, Kim JC, et al. Local control outcomes using stereotactic body radiation therapy for liver metastases from colorectal cancer. Int J Radiat Oncol Biol Phys. 2017;99(4):876–883. doi:10.1016/j.ijrobp.2017.07.03029063852
   PubMed Web of Science ®Google Scholar
• Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of liver metastases, part 1. AJR Am J Roentgenol. 2011;197(2):W256–W259. doi:10.2214/AJR.10.633121785050
   PubMed Web of Science ®Google Scholar
• Brendle C, Schwenzer NF, Rempp H, et al. Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series. Eur J Nucl Med Mol Imaging. 2016;43(1):123–132. doi:10.1007/s00259-015-3137-z26224536
   PubMed Web of Science ®Google Scholar
• Schulz A, Viktil E, Godt JC, et al. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI. Acta Radiol. 2016;57(9):1040–1048. doi:10.1177/028418511561734926622057
   PubMed Web of Science ®Google Scholar
• Riola-Parada C, García-Ca˜namaque L, Pérez-Due˜nas V, Garcerant-Tafur M, Carreras-Delgado JL. Simultaneous PET/MRI vs. PET/CT in oncology. A systematic review. Rev Esp Med Nucl Imagen Mol. 2016;35(5):306–312. doi:10.1016/j.remn.2016.06.00127424217
   PubMed Web of Science ®Google Scholar
• Devic S, Tomic N, Faria S, Menard S, Lisbona R, Lehnert S. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora’s box? Int J Radiat Oncol Biol Phys. 2010;78(5):1555–1562. doi:10.1016/j.ijrobp.2010.02.01520646840
   PubMed Web of Science ®Google Scholar
• Wang K, Mullins BT, Falchook AD, et al. Evaluation of PET/MRI for tumor volume delineation for head and neck cancer. Front Oncol. 2017;7(8). doi:10.3389/fonc.2017.00008
   Web of Science ®Google Scholar
• Bundschuh RA, Andratschke N, Dinges J, et al. Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases. Strahlenther Onkol. 2012;188(7):592–598. doi:10.1007/s00066-012-0094-322441441
   PubMed Web of Science ®Google Scholar
• Gondi V, Bradley K, Mehta M, et al. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;67(1):187–195. doi:10.1016/j.ijrobp.2006.09.03317189070
   PubMed Web of Science ®Google Scholar
• Wilson JM, Mukherjee S, Chu KY, Brunner TB, Partridge M, Hawkins M. Challenges in using 18F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer. Radiat Oncol. 2014;9:146. doi:10.1186/1748-717X-9-14624962658
   PubMed Web of Science ®Google Scholar
• Muijs CT, Schreurs LM, Busz DM, et al. Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer. Radiother Oncol. 2009;93(3):447–453. doi:10.1016/j.radonc.2009.08.03019765847
   PubMed Web of Science ®Google Scholar
• Ma JT, Han CB, Zheng JH, et al. Hybrid PET/MRI-based delineation of gross tumor volume in head and neck cancer and tumor parameter analysis. Nucl Med Commun. 2017;38(7):642–649. doi:10.1097/MNM.000000000000068728489688
   PubMed Web of Science ®Google Scholar
• Zhang SM, Xin J, Guo QY, Ma JT, Ma JT, Sun HZ. Comparison of tumor volume between PET and MRI in cervical cancer with hybrid PET/MR. Int J Gynecol Cancer. 2014;24(4):744–750. doi:10.1097/IGC.000000000000009724552896
   PubMed Web of Science ®Google Scholar
• Samolyk-Kogaczewska N, Sierko E, Zuzda K, Gugnacki P, Szumowski P. PET/MRI-guided GTV delineation during radiotherapy planning in patients with squamous cell carcinoma of the tongue. Strahlenther Onkol. 2019;195(9):780–791. doi:10.1007/s00066-019-01480-331214735
   PubMed Web of Science ®Google Scholar
• MacManus M, Nestle U, Rosenzweig KE, et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007. Radiother Oncol. 2009;91(1):85–94. doi:10.1016/j.radonc.2008.11.00819100641
   PubMed Web of Science ®Google Scholar
• Belli ML, Mori M, Broggi S, et al. Quantifying the robustness of [(18)F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and pancreatic cancer patients. Phys Med. 2018;49:105–111. doi:10.1016/j.ejmp.2018.05.01329866335
   PubMed Web of Science ®Google Scholar
• Zou KH, Warfield SK, Bharatha A, et al. Statistical validation of image segmentation quality based on a spatial overlap index. Acad Radiol. 2004;11(2):178–189. doi:10.1016/S1076-6332(03)00671-814974593
   PubMed Web of Science ®Google Scholar
• Riou O, Serrano B, Azria D, et al. Integrating respiratory-gated PET-based target volume delineation in liver SBRT planning, a pilot study. Radiat Oncol. 2014;9(1):127. doi:10.1186/1748-717X-9-12724885897
   PubMed Web of Science ®Google Scholar
• Ma DJ, Zhu JM, Grigsby PW. Tumor volume discrepancies between FDG-PET and MRI for cervical cancer. Radiother Oncol. 2011;98(1):139–142. doi:10.1016/j.radonc.2010.10.00420971521
   PubMed Web of Science ®Google Scholar